Merck ' s $11.5 Billion Bet on Its Next Big Drug Finally Arrives

The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.

Source: Reuters: Health - March 26, 2024 Category: Consumer Health News Source Type: news